Pfizer Vaccine Approved In Japan; Israeli Study Shows 94% Effective

Volkswagen and Audi to resume production in Mexico after gas shortages

Slideshow ( 2 images )

MEXICO CITY (Reuters) – The Mexican unit of Volkswagen AG will resume production of its Tiguan sports utility vehicle on Monday evening, the company said in a statement on Sunday, following gas shortages that hit swathes of Mexico last week.

Meanwhile, Audi will resume normal production levels at its plant in Puebla on Monday, after “the supply of hydrocarbons to the industrial sector was guaranteed,” the company said on Sunday.

NZXT Recalls H1 Computer Cases For Fire Risk

NZXT Inc. is recalling certain H1 computer cases citing a fire risk, the U.S. Consumer Product Safety Commission said.

The affected NZXT H1 computer cases are with model numbers CA-H16WR-W1 in matte white and CA-H16WR-B1 in matte black.

The recall involves about 32,000 units sold in the United States and about 1,024 units sold in Canada.

The serial numbers are 1200233400001 to 1203962204202, 00648999610844189725 to 00648999610844206361, and 0120AC00100001 to 01211C01900285.

The computer cases have a black tempered glass front with the NZXT brand name at the bottom. The model number and serial number are located on the bottom of the case.

The products were manufactured in China and sold online at and in electronic stores nationwide from February 2020 through February 2021 for about $350.

According to the agency, metal screws that attach the PCIe riser assembly to the chassis can cause a short in the printed circuit board and overheating. This could pose a fire hazard due to the circuit board’s design.

The City of Industry, California-based company initiated the recall after receiving 11 reports of circuit boards overheating or catching fire worldwide, six of which occurred in the U.S. However, no injuries have been reported to date.

Consumers are urged to contact NZXT for a free repair kit.

In similar recalls citing fire risks, Rapala USA in mid-January called back about 128,000 units of rechargeable fillet knives, and LG Energy Solution Michigan in December last year recalled about 1,815 units of Home Energy storage batteries.

Sheikha Latifa: The story behind tracking down a princess

For nearly three years, Princess Latifa, the daughter of Dubai ruler Sheikh Mohammed bin Rashid al Maktoum, has been missing. 

Sanya Burgess, from Sky’s data and forensics unit, managed to obtain videos of the royal who claimed she was a ‘hostage’.

In this episode of the Sky News Daily podcast, host Katerina Vittozzi speaks to Burgess about the time she has spent working with Latifa’s friends to get questions to the princess in order to tell her story.

US COVID Metrics Decline Sharply

COVID-19 metrics in the United States are declining sharply.

Only 64,194 new cases of coronavirus infections were reported in the country on Sunday, as per Johns Hopkins University’s latest data. This is the lowest daily number in several months. The total U.S. cases rose to 27640291.

During the same period, 1,084 pandemic-related deaths were reported across the country, taking the national total to 485336.

In terms of hospitalizations, the lowest number since November 17 was reported Sunday. A total of 67023 COVID patients are currently admitted in hospitals across the country, according to COVID Tracking Project.

“We continue to see cases, percent positive, hospitalizations, and ICU numbers in sharp decline,” according to the U.S. collaborative volunteer-run effort to track the pandemic. Reported deaths are now picking up the pace as well, declining in the 10-15 percent range week-over-week for about the past week, it wrote on Twitter.

Out of more than 1.40 million people who were tested for coronavirus on Monday, only 5.52 percent were diagnosed with the disease.

The US Centers for Disease Control and Prevention said that more than 70,000,000 vaccine doses have been distributed so far in the country. More than 52,000,000 doses of vaccine were administered to people.

Experts warned against more states relaxing Covid-19 restrictions in public places.

GardaWorld Confirms Its Increased Offer As Final Offer For G4S Plc

Garda World Security Corp. said the Group has decided to stay firm with its increased offer of 235 pence per share to acquire the entire issued and to be issued share capital of G4S plc.

Stephan Crétier, President and CEO of GardaWorld said: “We have concluded that priced above 235 pence per share, there are better and less risky opportunities available to GardaWorld. We will continue to capture such opportunities as we actively pursue our growth as a value-added partner of choice in the security and specialized services space.”

Pfizer Vaccine Approved In Japan; Israeli Study Shows 94% Effective

Pfizer-BioNTech’s Covid-19 vaccine has become the first vaccine to be approved in Japan against the coronavirus as the country prepares for the Tokyo Olympics. The vaccine, which was the first to get worldwide approval to combat the COVID-19, also found to be 94 percent effective in an Israeli study.

Japan’s Health Ministry on Sunday officially approved Pfizer vaccine following last week’s recommendation by a government panel after the country is stepping up efforts to beat the virus spread.

From next week, vaccinations are expected to begin with around 10,000 health workers, and the government hopes to vaccinate all by mid-year ahead of the Olympic Games that are scheduled to start by July 23.

As per reports, Japan would receive 144 million doses of Covid-19 vaccine from Pfizer, 120 million from AstraZeneca and about 50 million from Moderna.

The Japanese approval for the Pfizer vaccine comes at a time when an Israeli health care provider issued positive study results on more than half a million people who have received the recommended two doses of Pfizer vaccine.

As per reports, people are 94 percent less likely to have symptomatic COVID-19 infections after receiving the vaccine, and there were 92 percent fewer cases of severe illness due to the virus.

Pfizer’s Phase three clinical trial of the COVID-19 vaccine candidate, BNT162b2, showed the vaccine to be 95 percent effective.